Advanced search
Start date
Betweenand
Related content
(Reference retrieved automatically from Web of Science through information on FAPESP grant and its corresponding number as mentioned in the publication by the authors.)

Equine Yolk Sac: A Stem Cells Source

Full text
Author(s):
Franciolli, Andre Luis R. [1] ; Barreto, Rodrigo S. N. [1] ; Matias, Gustavo de Sa Schiavo [1] ; Carvalho, Rafael C. [2] ; Rodrigues, Marcio N. [1] ; Fratini, Paula [1] ; Pignatari, Graciela C. [1] ; Rechsteiner, Sandra M. E. F. [3] ; Mess, Andrea Maria [1] ; Miglino, Maria Angelica [1]
Total Authors: 10
Affiliation:
[1] Univ Sao Paulo, Sch Vet Med & Anim Sci, Dept Surg, Sao Paulo - Brazil
[2] Univ Fed Maranhao, Ctr Agr & Environm Sci, Chapadinha, Maranhao - Brazil
[3] Univ Fed Pelotas, Dept Morphol, Pelotas, RS - Brazil
Total Affiliations: 3
Document type: Journal article
Source: INTERNATIONAL JOURNAL OF MORPHOLOGY; v. 38, n. 5, p. 1412-1420, OCT 2020.
Web of Science Citations: 0
Abstract

SUMMARY: Mesenchymal stem cells are characterized by in vitro high proliferation and multilineage potential maintenance. This study aimed to isolate and characterize equine YS mesenchymal stem cells and compare these with amniotic membranes. The yolk sac (YS) and amniotic membranes (AM) were obtained from 20 pregnant mares with gestational age around 30 days. Cells were cultured in α-MEM supplemented with 15 % FBS, 1 % antibiotic solution, 1 % L-glutamine and 1 % nonessential amino acids. To cell characterization we used cytogenetic analysis, fibroblast colony-forming unit assays, cell growth curves, immunophenotyping, flow cytometry, differentiation assays and teratoma formation. Results: Both cell sources presented fibroblastoid and epithelioid-like format. The YS cells have lower colony formation potential then AM ones, 3 versus 8 colonies per 103 plated cells. However, YS cells grew progressively while AM cells showed steady. Both, the YS and amnion cells immunolabeled for Oct-4, Nanog, SSEA-3, cytokeratin 18, PCNA, and vimentin. In addition, presented mesenchymal, hematopoietic, endothelial and pluripotency markers in flow cytometry. Discussion: Both cell sources presented high plasticity and differed into osteogenic, adipogenic, and chondrogenic lineages, and no tumor formation in nude mice was observed. The results suggest that horse YS may be useful for cell therapy such as amnion-derived cells. (AU)